Search for content and authors |
Effect of valproic acid and cisplatin on the proliferation of tumor cell lines A375 and C32 |
Ewa Chodurek 1, Arkadiusz Orchel 1, Arkadiusz R. Gruchlik 1, Ewelina Aleksander 1, Karolina Gołąbek 2, Zofia Dzierżewicz 1 |
1. Department of Biopharmacy, Medical University of Silesia, Narcyzów 1, Sosnowiec 41-200, Poland |
Abstract |
An early diagnosis, in the initial phase of development of melanoma malignum, increases the chance of complete recovery, whereas the advanced stage of melanoma is almost fully resistant to all available therapies. Surgical removal of the lesion is the primary method of melanoma regimen, whereas radio-, chemo- and immunotherapy are a supplementary treatment. From among platinum – based chemotherapeutic drugs, cisplatin (cis-diamminedichloroplatinum, CPT) was the first used in treatment of melanoma. However, CPT has a low efficacy in therapy of melanoma, which is associated with cell resistance to this drug, and high toxicity. For this reason, novel therapeutic strategies are sought (analogues of cisplatin). A new promising group of compounds used in the therapy of melanoma are histone deacetylase (HDAC) inhibitors. One of them is valproic acid (2-propylpentanoic acid, VPA) which undergoes phase I and II clinical trials.
The aim of our study was to evaluate the influence of valproic acid and cisplatin on morphology and growth rate in human melanoma cell lines: A375 (melanotic) and C32 (amelanotic). Cell proliferation was measured using sulforhodamine B (In Vitro Toxicology Assay Kit, Sigma-Aldrich), a dye binding to cellular proteins. Our results suggest that CPT and VPA exerted synergistic inhibitory effect on the growth of both studied cell lines. Cisplatin alone inhibited the cell growth at concentrations ≥0.3 μM. Inhibitory effect of valproic acid was seen at concentrations ≥1 mM. However, the combination of both compounds displayed the strongest cytotoxic effect. |
Legal notice |
|
Related papers |
Presentation: Poster at VIII Multidyscyplinarna Konferencja Nauki o Leku, by Ewa ChodurekSee On-line Journal of VIII Multidyscyplinarna Konferencja Nauki o Leku Submitted: 2012-03-12 08:42 Revised: 2012-03-19 07:44 |